PCSK9 and ischemic stroke: Another previous study recruited 1646 patients with acute MI (84.9% presenting with STEMI and only 47.5% undergoing reperfusion therapy) and showed that the baseline PCSK9 levels did not predict MACEs (including cardiac death, nonfatal MI, coronary revascularization, and ischemic stroke) within 1 year [9].